Search

Searching. Please wait…

Pathophysiological mechanisms in non-alcoholic fatty liver disease: from drivers to targets

Abstract: Non-alcoholic fatty liver disease (NAFLD) is characterized by the excessive and detrimental accumulation of liver fat as a result of high-caloric intake and/or cellular and molecular abnormalities. The prevalence of this pathological event is increasing worldwide, and is intimately associated with obesity and type 2 diabetes mellitus, among other comorbidities. To date, only therapeutic strategies based on lifestyle changes have exhibited a beneficial impact on patients with NAFLD, but unfortunately this approach is often difficult to implement, and shows poor long-term adherence. For this reason, great efforts are being made to elucidate and integrate the underlying pathological molecular mechanism, and to identify novel and promising druggable targets for therapy. In this regard, a large number of clinical trials testing different potential compounds have been performed, albeit with no conclusive results yet. Importantly, many other clinical trials are currently underway with results expected in the near future. Here, we summarize the key aspects of NAFLD pathogenesis and therapeutic targets in this frequent disorder, highlighting the most recent advances in the field and future research directions.

 Fuente: Biomedicines 2022, 10(1), 46, 1-48

 Publisher: MDPI AG

 Year of publication: 2022

 No. of pages: 48

 Publication type: Article

 DOI: 10.3390/biomedicines10010046

 ISSN: 2227-9059

 Publication Url: https://doi.org/10.3390/biomedicines10010046

Authorship

ALVARO SANTOS LASO

MARIA GUTIERREZ LARRAÑAGA

PAULA IRUZUBIETA COZ

JAVIER CRESPO GARCIA